Dec. 6, 2023—CellNetix Pathology and Laboratories and Proscia announced today that CellNetix has selected Proscia to digitize a portion of its volume of 1 million glass slides scanned per year.
“At CellNetix, we are mission-driven and pride ourselves on quality and delivering more precise results. Adopting digital pathology is critical to furthering this aim,” Kathleen Fondren, CEO of CellNetix, said in a press release. “Proscia has established itself as a leading player in the space, and we are confident that working with the team will enable us to quickly realize the unprecedented potential of this innovation.”
CellNetix is private pathology company headquartered in Tukwila, Wash., that serves hospitals and clients throughout the Pacific Northwest.